Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Azn crawled time : 12:00 save search
FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
AZNCF | News | $138.73 1.86% -4.19% 0
|
Health Technology
|
| O: 1.47%
H: 1.16%
C: -1.27%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: 3.34%
H: 0.27%
C: -0.62%
children approved treatment for
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
AZNCF | News | $138.73 1.86% -4.19% 0
|
Health Technology
|
| O: 0.75%
H: 0.04%
C: -0.1%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: -0.08%
H: 0.33%
C: -0.53%
ARTL | News | $1.3004 -1.11% 1.87% 3.5K
|
Health Technology
|
| O: -4.61%
H: 4.83%
C: 3.84%
business update financial results
AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer
Published: 2024-03-19 (Crawled : 12:00) - biospace.com/
FUSN | $21.32 0.28% 0.3% 340K
|
Health Technology
|
| O: 96.99%
H: 1.19%
C: 1.05%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: -0.38%
H: 0.46%
C: 0.4%
astrazeneca cancer treat acquire
Eplontersen granted U.S. FDA Fast Track designation for patients with transthyretin-mediated amyloid cardiomyopathy
Published: 2024-02-08 (Crawled : 12:00) - prnewswire.com
AZNCF | News | $138.73 1.86% -4.19% 0
|
Health Technology
|
| O: -8.5%
H: 2.46%
C: 2.46%
IONS | $41.07 0.96% 0.97% 710K
|
Health Technology
|
| O: 0.2%
H: 1.37%
C: 0.68%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: -6.81%
H: 3.02%
C: 2.42%
fda granted designation eplontersen
Ionis poised for continued momentum in 2024 with product launches and key advances in robust pipeline of investigational medicines for serious diseases
Published: 2024-01-08 (Crawled : 12:00) - prnewswire.com
AZNCF | News | $138.73 1.86% -4.19% 0
|
Health Technology
|
| O: 2.71%
H: 0.36%
C: 0.11%
IONS | $41.07 0.96% 0.97% 710K
|
Health Technology
|
| O: -0.3%
H: 3.6%
C: 3.5%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: 0.28%
H: 0.99%
C: 0.93%
momentum pipeline key
Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
Published: 2024-01-08 (Crawled : 12:00) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 2.29%
H: 8.38%
C: 4.47%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: 0.28%
H: 0.99%
C: 0.93%
first million payment astrazeneca cancer trial milestone
Compugen Reports Third Quarter 2023 Results
Published: 2023-11-07 (Crawled : 12:00) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: -5.83%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: -0.59%
H: 0.46%
C: -0.09%
results
Pfizer Reports Third-Quarter 2023 Results
Published: 2023-10-31 (Crawled : 12:00) - biospace.com/
HLNCF | $4.13 4.56% -1.48% 0
|
n/a
|
| O: 2.0%
H: 0.5%
C: 0.5%
HLN | $8.36 1.7% 0.0% 3.8K
|
n/a
|
| O: 0.75%
H: 0.74%
C: 0.12%
AZNCF | News | $138.73 1.86% -4.19% 0
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.7%
PFE | News A | $26.26 1.0% 0.38% 29M
|
Health Technology
|
| O: -0.87%
H: 1.77%
C: 0.91%
BNTX | News | $88.01 1.38% 1.36% 240
|
Health Technology
|
| O: -1.65%
H: 2.78%
C: 2.0%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: 0.08%
H: 0.41%
C: 0.38%
results
Fusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2068, a Novel Targeted Alpha Therapy for EGFR-cMET Expressing Cancers
Published: 2023-10-12 (Crawled : 12:00) - biospace.com/
FUSN | $21.32 0.28% 0.3% 340K
|
Health Technology
|
| O: 0.55%
H: 3.26%
C: 1.09%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: 0.6%
H: 0.34%
C: -0.45%
fpi-2068 presentation pharmaceuticals preclinical therapy
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Demonstrated Clinically Meaningful Progression-Free Survival and Overall Survival Across Multiple HER2-Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase II Trial
Published: 2023-07-27 (Crawled : 12:00) - biospace.com/
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: 0.42%
H: 0.55%
C: -0.86%
enhertu tumors trial
Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027|Growing prevalence of chronic diseases to boost market growth - Technavio
Published: 2023-07-04 (Crawled : 12:00) - prnewswire.com
AMGN | News | $271.91 1.11% 1.12% 560
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 5.4% 6.88% 490
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 77
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.15 1.84% 1.75% 2M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $95.12 0.81% 5.43% 2.3M
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $138.73 1.86% -4.19% 0
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $167.89 0.89% 0.51% 3.6M
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $548.38 0.66% 0.86% 1.2M
|
Health Technology
| Email alert
Add to watchlist
growth market
Revvity Announces New License Agreement for Next-Generation Base Editing Technology
Published: 2023-05-18 (Crawled : 12:00) - biospace.com/
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: 0.28%
H: 0.31%
C: -0.93%
license technology agreement
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology
Published: 2023-03-02 (Crawled : 12:00) - globenewswire.com
AZNCF | News | $138.73 1.86% -4.19% 0
|
Health Technology
|
| O: 0.86%
H: 1.43%
C: 1.43%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: -1.43%
H: 1.34%
C: 1.28%
Pulmonary Arterial Hypertension (PAH) Drugs Global Market 2022: Sector to Reach $9.4 Billion by 2027 at a CAGR of 5.29%
Published: 2023-02-03 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 0
|
Health Technology
|
| O: 0.12%
H: 0.58%
C: 0.52%
AZNCF | News | $138.73 1.86% -4.19% 0
|
Health Technology
|
| O: -0.63%
H: 2.15%
C: 1.68%
JNJ | News | $149.12 0.82% 0.59% 440K
|
Health Technology
|
| O: 0.3%
H: 0.19%
C: -0.86%
GSK | News | $40.59 2.11% 0.1% 1.3K
|
Health Technology
|
| O: 0.71%
H: 0.42%
C: -1.55%
UTHR | $234.06 -1.63% -1.67% 310K
|
Health Technology
|
| O: -0.1%
H: 1.37%
C: -2.48%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: 0.79%
H: 0.69%
C: -0.33%
global hypertension market
Biosimilar Therapeutic Peptides Global Market to Reach $3.5 Billion by 2026 at a CAGR of 30.3%
Published: 2022-12-06 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 77
|
Health Technology
|
| O: 0.74%
H: 8.46%
C: 8.46%
NVSEF | News | $95.11 5.4% 6.88% 490
|
Health Technology
|
| O: -1.97%
H: 0.05%
C: 0.05%
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
|
| O: -0.85%
H: 0.46%
C: -0.17%
NVS | News | $95.12 0.81% 5.43% 2.3M
|
Health Technology
|
| O: 0.03%
H: 0.26%
C: -0.27%
SNY | News | $47.15 1.84% 1.75% 2M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: -0.48%
H: 1.59%
C: 0.69%
AMGN | News | $271.91 1.11% 1.12% 560
|
Health Technology
|
| O: 0.33%
H: 0.56%
C: -0.89%
global biosimilar market
Cancer Gene Therapy Market To Reach a Valuation of USD 4047.8 Million by 2028 - Comprehensive Research Report by BrandEssence Market Research
Published: 2022-12-02 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 0
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: -3.13%
AZNCF | News | $138.73 1.86% -4.19% 0
|
Health Technology
|
| O: -0.61%
H: 0.08%
C: -0.29%
NVS | News | $95.12 0.81% 5.43% 2.3M
|
Health Technology
|
| O: -1.08%
H: 1.44%
C: 1.28%
GSK | News | $40.59 2.11% 0.1% 1.3K
|
Health Technology
|
| O: -0.29%
H: 1.55%
C: 1.2%
CRNX G | $43.44 1.09% 1.1% 470K
|
Health Technology
|
| O: -0.57%
H: 5.9%
C: 5.44%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: -0.23%
H: 0.79%
C: 0.43%
ADAP | $1.01 3.41% 5.17% 100
|
Health Technology
|
| O: -0.99%
H: 6.5%
C: 3.0%
research report therapy cancer market
Global Immuno-oncology Market Report to 2028: An Increase in the Research and Development in Cancer Immunotherapy Will Be Driving Growth
Published: 2022-11-28 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 0
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: -2.51%
AZNCF | News | $138.73 1.86% -4.19% 0
|
Health Technology
|
| O: -0.38%
H: 1.09%
C: 0.87%
NVSEF | News | $95.11 5.4% 6.88% 490
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: -0.68%
NVS | News | $95.12 0.81% 5.43% 2.3M
|
Health Technology
|
| O: 0.29%
H: 0.45%
C: -0.32%
GSK | News | $40.59 2.11% 0.1% 1.3K
|
Health Technology
|
| O: -0.65%
H: 0.83%
C: -0.03%
LLY | News | $731.33 0.69% 0.73% 12K
|
Health Technology
|
| O: -0.49%
H: 1.67%
C: 0.64%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: 0.12%
H: 0.97%
C: -0.06%
research global immunotherapy report cancer growth market
Global Enzyme Inhibitor Market Report 2022-2026 & 2031: Major Companies Such as Abbott, Amgen, AstraZeneca, Bayer, & F. Hoffmann-La Roche are Focused on Strategic Partnerships to Meet Demand
Published: 2022-11-03 (Crawled : 12:00) - prnewswire.com
AZNCF | News | $138.73 1.86% -4.19% 0
|
Health Technology
|
| O: -2.33%
H: 3.2%
C: 3.2%
LLY | News | $731.33 0.69% 0.73% 12K
|
Health Technology
|
| O: -0.25%
H: 2.48%
C: 2.15%
ABT | News | $107.07 -0.2% 0.18% 3.8M
|
Health Technology
|
| O: -1.25%
H: 0.21%
C: -0.37%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: -1.31%
H: 1.98%
C: 1.71%
AMGN | News | $271.91 1.11% 1.12% 560
|
Health Technology
|
| O: -0.18%
H: 0.03%
C: -0.99%
global companies report roche market
Invitae Announces Partnership for Real-World Data Sharing to Inform Rare Cancer Research
Published: 2022-10-27 (Crawled : 12:00) - biospace.com/
NVTA | News | $0.019 0.0% 22M
|
Health Services
|
| O: 0.6%
H: 1.8%
C: -8.62%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: -0.48%
H: 0.56%
C: -0.12%
partnership rare research cancer
Influenza Vaccine Market to grow by USD 2.56 Bn by 2026, Market Segmentation by Type and Geography - Technavio
Published: 2022-10-19 (Crawled : 12:00) - prnewswire.com
CMXHF | $176.0 1.59% -19.21% 0
|
n/a
|
| O: -0.59%
H: 0.0%
C: 0.0%
CSLLY | $89.17 2.7% 3.3% 0
|
n/a
|
| O: 0.38%
H: 0.24%
C: -0.31%
AZNCF | News | $138.73 1.86% -4.19% 0
|
Health Technology
|
| O: -1.21%
H: 3.64%
C: -0.28%
GSK | News | $40.59 2.11% 0.1% 1.3K
|
Health Technology
|
| O: 0.96%
H: 0.22%
C: -0.76%
BAX | $40.4 2.36% 0.0% 2.7M
|
Health Technology
|
| O: -0.36%
H: 1.95%
C: -0.14%
SNY | News | $47.15 1.84% 1.75% 2M
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: 0.0%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: -0.05%
H: 0.13%
C: -2.56%
vaccine influenza market
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M
|
Finance
EDBL | News | $6.26 66.49% 48.56% 270K
|
SILO | $1.99 0.71% 20.64% 1.8M
|
Finance and Insurance
CANG | $1.34 -4.29% 14.93% 120K
|
Technology Services
AZTR 4 | $0.195 13.85% 42K
|
n/a
TOVX | News | $0.411 -1.01% 12.9% 230K
|
Manufacturing
IBRX | $4.94 -6.26% 10.83% 4.5M
|
Manufacturing
CISS | $1.3 11.11% 10.0% 42K
|
n/a
SQNS | $0.504 -9.19% 9.25% 110K
|
Electronic Technology
CR | $130.73 0.97% 8.82% 230K
|
Producer Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.